Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention
due to its rapid transmission, which has infected more than two million people worldwide …

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward | Science
Immunology news careers commentary Journals Science Science brought to you byGoogle …

Critical to managing the spread of COVID-19 is the ability to diagnose infection and define
the acquired immune response across the population. While genomic tests for the novel …

The role of serologic testing for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), in both the clinical and public health settings, will continue to evolve as we gain …

C oronavirus disease 2019 (COVID-19) is an infectious dis-ease caused by severe acute
respiratory syndrome corona-virus 2 (SARS-CoV-2), which first appeared in Wuhan, China …

Serology is a crucial part of the public health response to the ongoing SARS-CoV-2
pandemic. Here, we describe the development, validation and clinical evaluation of a …

A new coronavirus, SARS-CoV-2, has recently emerged to cause a human pandemic.
Whereas molecular diagnostic tests were rapidly developed, serologic assays are still …

In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has led to significant morbidity and mortality …

Objectives To examine and summarize the current literature on serologic methods for the
detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …